Company Filing History:
1 out of 64 
1 out of 1 Years Active: 2017
Title: Iris Barshack: Innovator in Cancer Classification
Introduction
Iris Barshack is a prominent inventor based in Tel Aviv, Israel, known for her significant contributions to the field of cancer research. With a focus on microRNA expression, she has developed innovative methods for determining the origin of tumors, which can greatly enhance treatment options for patients.
Latest Patents
Iris Barshack holds a patent for a groundbreaking invention titled "MicroRNAs expression signature for determination of tumors origin." This invention provides a process for classifying specific cancers and tumors based on the analysis of expression patterns of specific microRNAs and related nucleic acid molecules. By utilizing a microRNA expression framework, her invention allows for the optimization of treatment and the determination of specific therapies tailored to individual patients.
Career Highlights
Throughout her career, Iris has worked with notable companies in the medical and biotechnology sectors, including Rosetta Genomics Ltd. and Tel Hashomer Medical Infrastructure and Services Ltd. Her work in these organizations has contributed to advancements in cancer diagnostics and treatment methodologies.
Collaborations
Iris has collaborated with esteemed colleagues, including Nitzan Rosenfeld and Shai Rosenwald, to further her research and innovations in the field of cancer classification.
Conclusion
Iris Barshack's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer research. Her contributions have the potential to transform how tumors are classified and treated, ultimately improving patient outcomes.